Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model

Journal of Neuroimmunology

Volumn 95, Issue 1-2, 1999, Pages 107-114

  Roy, Sabita ^a   Charboneau, Richard G ^a   Barke, Roderick A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Endotoxin; Immune cells; Lipopolysaccharide; Morphine; TH1 TH2 elaboration

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; ELECTIVE SURGERY; ENDOTOXEMIA; IMMUNOCOMPETENT CELL; MITOGENESIS; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEPSIS; SYNTHESIS;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; ENDOTOXEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED ICR; MORPHINE; NARCOTICS; ORGAN SIZE; PITUITARY GLAND; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033103748     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00265-3     Document Type: Article

References (29)

1. Abraham E., Regan R.F. The effects of hemorrhage and trauma on IL-2 production. Arch. Surg. 120:1985;1341-1344.
2. Barke R.A., Roy S., Chapin R., Charboneau R. The role of programmed cell death (apoptosis) in thymic involution following sepsis. Arch. Surg. 129:1994;1256-1262.
3. Barke R.A., Roy S., Chapin R., Charboneau R. Sepsis induced release of interleukin-6 may activate the immediate early gene program through a hypothalamic-hypophyseal mechanism. Surgery. 116:1994;141-149.
4. Bayer B.M., Daussin S., Hernandez M., Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology. 29:1990;369-374.
5. Brown S.M., Stimmel B., Taub R.N., Kochwa S., Rosenfeld R.E. Immunological dysfunction in heroin addicts. Arch. Int. Med. 134:1974;1001-1006.
6. Bryant H.U., Yoburn B.C., Intrissi C.E., Bernton E.W., Holaday J.W. Immunosuppressive effects of chronic morphine treatment. Eur. J. Pharm. 149:1988;165-169.
7. Bryant H.U., Bernton E.W., Kenner J.R., Holaday J.W. Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology. 128(6):1991;3253-3258.
8. Cantacuzene J. Nouvelles recherches sur le monde de destruction des vibrions dans l'organisme. Ann. Inst. Pasteur. 12:1898;273-300.
9. Carr D.J.J., Kim C.-H., DeCosta B.R., Jacobson A.E., Rice K.C., Blalock J.R. Evidence for a κ-class opioid receptor on cells of the immune system. Cell. Immunol. 116:1988;44-51.
10. Chao C.C., Sharp B.M., Pomeroy C., Filice G.A., Peterson P.K. Lethality of morphine in mice infected with Toxoplasma gondii. J. Pharmacol. Exp. Ther. 252:1990;605-609.
11. Christou N.V., Meakins J.L., Gordon J., Yee J., Hassan Z.M., Nohr C.W., Shizgal H.M., Maclean D. The delayed hypersensitivity response and host resistance in surgical patients. Ann. Surg. 222:1995;534-546.
12. George R., Way E.L. Studies on the mechanism of pituitary-adrenal activation by morphine. Br. J. Pharm. 10:1955;260-264.
13. Gungor M., Genc E., Sogduyu H., Eroglu L., Koyuncuoglu H. Effect of chronic administration of morphine on primary immune response in mice. Experientia (Basel). 36:1980;1309-1310.
14. Lefkowit S.S., Chiang C.Y. Effects of certain abused drugs on hemolysin forming cells. Life Sci. 17:1975;1763-1768.
15. Lin R.Y., Astiz M.E., Saxon J.C., Rackow E.C. Altered leukocytes immunophenotypes in septic shock. Chest. 104:1993;847-853.
16. Louria D.B., Hensle T., Rose J. The major medical complications of heroin addiction. Ann. Int. Med. 67:1974;1-22.
17. Loyd D.A., Teich S., Rowe M.I. Serum endorphins levels in injured children. Surg. Gyn. Obstet. 172:1991;449-452.
18. McDonough R.J., Madden J.J., Falek A., Shafer D.A., Pline M., Gordon D., Bokos P., Kuehnle J.C., Mendelson J. Alterations of T and Null lymphocyte frequencies in the peripheral blood of human opiate addicts. J. Immunol. 125:1980;2539.
19. Rodrick M.L., Wood J.J., O'Mahony J.B. Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man. J. Clin. Invest. 6:1986;310.
20. Roy S., Loh H.H. Effects of opioids on the immune system. Neurochem. Res. 21(11):1996;1373-1384.
21. 3H -morphine binding to interleukin-1 activated thymocytes J. Pharm. Exp. Ther. 263:1992;45-451.
22. Roy S., Loh H.H., Barke R.A. Morphine induced suppression of thymocyte proliferation is mediated by inhibition of IL-2 synthesis. Adv. Exp. Med. Biol. 373:1995;41-48.
23. Roy S., Chapin R., Cain K., Charboneau R., Ramakrishnan S., Barke R.A. Morphine inhibits transcriptional regulation of IL-2 synthesis in thymocytes. Cell. Immunol. 179:1997;1-9.
24. Shavit Y., Martin F.C., Angarita L.H., Gale R.P., Liebeskind J.C. Morphine-induced suppression of natural killer cell activity is mediated by the adrenal gland. Soc. Neurosci. Abstr. 12:1986;339.
25. Sibinga N.E.S., Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Ann. Rev. Immunol. 6:1988;219-249.
26. Tubaro E., Avico U., Santiangeli C., Zuccaro P., Cavallo G., Pacifici R., Croce C., Borelli G. Morphine and methadone impact of human phagocytic physiology. Int. J. Immunopharmacol. 7:1985;865-874.
27. Wood J.J., Rodrick M.L., O'Mahony J.B. Inadequate IL-2 production; a fundamental immunologic deficiency in patients with major burns. Ann. Surg. 200:1984;311-320.
28. Woolf P.D. Hormonal responses to trauma. Crit. Care Med. 20:1992;216-226.
29. Wybran J., Appelboon T., Famey J.P., Govaerts A. Suggestive evidence for receptors for morphine and methionine enkephalin on normal human blood T-lymphocytes. J. Immunol. 123:1979;1068-1070.